Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections
Por:
Rojo-Marcos G, Rubio-Muñoz JM, Angheben A, Jaureguiberry S, García-Bujalance S, Tomasoni LR, Rodríguez-Valero N, Ruiz-Giardín JM, Salas-Coronas J, Cuadros-González J, García-Rodríguez M, Molina-Romero I, López-Vélez R, Gobbi F, Calderón-Moreno M, Martin-Echevarría E, Elía-López M, Llovo-Taboada J, TropNet Plasmodium ovale investigator group
Publicada:
30 oct 2018
Resumen:
BackgroundFew previous retrospective studies suggest that Plasmodium
ovale wallikeri seems to have a longer latency period and produces
deeper thrombocytopaenia than Plasmodium ovale curtisi. Prospective
studies were warranted to better assess interspecies
differences.MethodsPatients with imported P. ovale spp. infection
diagnosed by thick or thin film, rapid diagnostic test (RDT) or
polymerase chain reaction (PCR) were recruited between March 2014 and
May 2017. All were confirmed by DNA isolation and classified as P. o.
curtisi or P. o. wallikeri using partial sequencing of the ssrRNA gene.
Epidemiological, analytical and clinical differences were analysed by
statistical methods.ResultsA total of 79 samples (35 P. o. curtisi and
44 P. o. wallikeri) were correctly genotyped. Males predominate in
wallikeri group (72.7%), whereas were 48.6% in curtisi group.
Conversely, 74.3% of curtisi group were from patients of African
ethnicity, whilst 52.3% of Caucasians were infected by P. o. wallikeri.
After performing a multivariate analysis, more thrombocytopaenic
patients (p=0.022), a lower number of platelets (p=0.015), a higher INR
value (p=0.041), and shorter latency in Caucasians (p=0.034) were
significantly seen in P. o. wallikeri. RDT sensitivity was 26.1% in P.
o. curtisi and 42.4% in P. o. wallikeri. Nearly 20% of both species were
diagnosed only by PCR. Total bilirubin over 3mg/dL was found in three
wallikeri cases. Two patients with curtisi infection had haemoglobin
under 7g/dL, one of them also with icterus. A wallikeri patient suffered
from haemophagocytosis. Chemoprophylaxis failed in 14.8% and 35% of
curtisi and wallikeri patients, respectively. All treated patients with
various anti-malarials which included artesunate recovered. Diabetes
mellitus was described in 5 patients (6.32%), 4 patients of wallikeri
group and 1 curtisi.ConclusionsImported P. o. wallikeri infection may be
more frequent in males and Caucasians. Malaria caused by P. o. wallikeri
produces more thrombocytopaenia, a higher INR and shorter latency in
Caucasians and suggests a more pathogenic species. Severe cases can be
seen in both species. Chemoprophylaxis seems less effective in P. ovale
spp. infection than in P. falciparum, but any anti-malarial drug is
effective as initial treatment. Diabetes mellitus could be a risk factor
for P. ovale spp. infection.
Filiaciones:
Rojo-Marcos G:
Hospital Universitario Príncipe de Asturias, Ctra de Meco s/n, 28805, Alcalá de Henares, Madrid, Spain.
Rubio-Muñoz JM:
Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
Angheben A:
Ospedale Sacro Cuore - Don Calabria, Negrar, Verona, Italy
Jaureguiberry S:
Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
García-Bujalance S:
Hospital Universitario La Paz-Carlos III, Madrid, Spain
Tomasoni LR:
Spedali Civili Hospital, University of Brescia, Brescia, Italy
Rodríguez-Valero N:
Hospital Clinic, Barcelona, Spain
Ruiz-Giardín JM:
Hospital Universitario de Fuenlabrada, Madrid, Spain
Salas-Coronas J:
Hospital del Poniente-El Ejido, Almería, Spain
Cuadros-González J:
Hospital Universitario Príncipe de Asturias, Ctra de Meco s/n, 28805, Alcalá de Henares, Madrid, Spain
García-Rodríguez M:
Hospital General Universitario de Valencia, Valencia, Spain
Molina-Romero I:
Hospital Vall D´Hebron-Drassanes, Barcelona, Spain
López-Vélez R:
Hospital Universitario Ramon y Cajal, Madrid, Spain
Gobbi F:
Ospedale Sacro Cuore - Don Calabria, Negrar, Verona, Italy
Calderón-Moreno M:
Hospital Universitario Gregorio Marañón, Madrid, Spain
Martin-Echevarría E:
Hospital Universitario de Guadalajara, Guadalajara, Spain
Elía-López M:
Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
Llovo-Taboada J:
Complejo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain
|